# US 2013/0156697 A1 · Isolated protein medicament

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156697 A1
- Document ID: US20130156697A1
- Status: Published application
- Kind: A1
- Application number: 13/724,753
- Filed: 2012-12-21
- Published: 2013-06-20
- Earliest claimed: 2009-03-06
- Inventors: FRANCO VITALIANO; GORDANA DRAGAN VITALIANO
- Web page: https://patentgrep.com/patent/US20130156697A1

## CPC

- A61K 9/5169: {Proteins, e.g. albumin, gelatin}
- A61K 47/62: the modifying agent being a protein, peptide or polyamino acid
- A61K 38/17: from animals; from humans {(enzyme inhibitors A61K38/005)}
- A61K 38/1709: {from mammals}
- A61K 38/45: Transferases (2)
- A61K 38/465: {acting on ester bonds (3.1), e.g. lipases, ribonucleases}
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- C07K 14/47: from mammals
- C12N 9/0051: {acting on a sulfur group of donors (1.8)}
- C12Y 205/01018: Glutathione transferase (2.5.1.18)
- C12Y 301/03048: Protein-tyrosine-phosphatase (3.1.3.48)
- A61K 9/0085: {Brain, e.g. brain implants; Spinal cord}
- A61K 47/6949: {inclusion complexes, e.g. clathrates, cavitates or fullerenes}
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- C07K 2319/23: containing a GST-tag
- Y10S 977/773: Nanoparticle, i.e. structure having three dimensions of 100 nm or less
- Y10S 977/795: Composed of biological material
- Y10S 977/904: for medical, immunological, body treatment, or diagnosis
- Y10S 977/906: Drug delivery
- Y10S 977/919: Dental
- Y10S 977/923: Cell culture
- Y10S 977/932: for electronic or optoelectronic application
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The invention in suitable embodiments is directed to an isolated protein comprising one or more amino acid sequences, each amino acid sequence capable of being functionalized and/or attached in whole and/or in part to one or more or a plurality of elements of one or more types including to cargo elements, forming a composition of elements suitable for use as an in vivo and/or in vitro medicament to treat one or more biological species.

## Claims

### Claim 1

A selectively configurable, isolated protein element comprising in whole and/or in part one or more configurations of elements comprised of one or more isolated amino acid sequence elements selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29 and SEQ ID NO: 30, the isolated protein element optionally comprising in part one or more supplementary configurations of elements, one or more selected configurations of aforesaid elements comprising one or more compositions acceptable for use as an in vivo and/or in vitro medicament in one or more biological species.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

A selectively configurable, isolated protein element according to claim 1 wherein one or more configurations of protein elements comprise in whole and/or in part one or more full-length proteins of one or more distinct domains and segments and/or one or more less than full length proteins of one or more domains and segments.

### Claim 4

(canceled)

### Claim 5 (depends on 1)

A selectively configurable, isolated protein element according to claim 1 wherein one or more configurations of selected amino acid sequences comprise in whole and/or in part one or more isoforms of amino acid sequences.

### Claim 6 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more configurations of protein elements comprise in whole and/or in part one or more recombinant and/or synthetic elements of one or more types.

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10

(canceled)

### Claim 11 (depends on 1)

A selectively configurable, isolated protein element according to claim 1 wherein one or more compositions of elements comprise in whole and/or in part one or more types of targeted and/or non-targeted elements.

### Claim 12 (depends on 1)

A selectively configurable, isolated protein element according to claim 1 wherein one or more compositions of elements are formed in whole and/or in part into one or more types of therapeutic scaffolding and/or nanoscale structures of one or more geometry.

### Claim 13 (depends on 1)

A selectively configurable, isolated protein element according to claim 1 wherein one or more types of coatings cover part or the entirety of one or more compositions of elements.

### Claim 14 (depends on 1)

A selectively configurable, isolated protein element according to claim 1 and one or more compositions of elements and pharmaceutically acceptable carriers, or excipients and optionally immunological elements, said carriers selected from aerosol, agricultural, airborne, adhesive, apparel, bandage, biological, biomedical, biomedical device, capsule, chemical, chemical compound, chewable, clothing, crystal, edible, food, gas, hydrogel, injection, liquid borne element, liquid, nano-device, nano-particle, powder, subcutaneous, syrup, tablet, topical carrier elements.

### Claim 15 (depends on 1)

A selectively configurable, isolated protein element according to claim 1 wherein one or more compositions of elements comprise in whole and/or in part one or more adjunctive elements.

### Claim 16

(canceled)

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more configurations of protein elements comprise in whole and/or in part one or more protein elements modified by one more acceptable methods.

### Claim 20 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable in whole and/or in part of therapeutically interacting with and/or regulating one or more types of cells, cellular components, and/or cellular processes.

### Claim 21 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable of being incorporated in whole and/or in part into one or more types of biomedical elements and/or devices.

### Claim 22 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable in whole and/or in part of following and/or executing one or more algorithms.

### Claim 23 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements comprise in whole and/or in part one or more multifunction elements.

### Claim 24 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements in whole and/or in part are therapeutic and/or diagnostic elements.

### Claim 25 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable in whole and/or in part of responding to one or more in vivo and/or in vitro conditions.

### Claim 26 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable in whole and/or in part of crossing an intact and/or non-intact blood brain barrier.

### Claim 27 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable in whole and/or in part of moving through synaptic spaces of a central nervous system.

### Claim 28 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable in whole and/or in part of being stable and/or remaining bioactive post administration.

### Claim 29 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements respond in whole and/or in part to one or more stimuli selected from acoustical, biochemical, biochemical, biological, chemical, covalent, electrical, electromagnetic, fluidic, fluorescent, mechanical, metabolic, non-covalent, optical, pH, photo-electrical, photonic, quantum mechanical, radioactive stimulus, radioactive, sonic, thermal stimuli.

### Claim 30 (depends on 14)

The composition of claim 14, wherein said pharmaceutically acceptable carriers in whole and/or in part respond to one or more in vivo and/or in vitro conditions.

### Claim 31 (depends on 14)

The composition of claim 14, wherein said pharmaceutically acceptable carriers comprise in whole and/or in part a controlled release formulation.

### Claim 32 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable in whole and/or in part of diagnosing, remedying, inhibiting, mitigating, and/or preventing one or more diseases and/or disorders selected from a cellular process disease or disorder, a cellular organelle disease or disorder, an endocytosis disease or disorder, an exocytosis disease or disorder, a mitosis disease or disorder, a cell trafficking disease or disorder, a cell signaling disease or disorder, a cell receptor upregulation disease or disorder, a cell receptor downregulation disease or disorder, a degenerative cellular disease or disorder, a cell cycle regulation disease or disorder, a lysosomal regulation disease or disorder, a genetic disease or disorder, an infectious disease or disorder, an immunological disease or disorder, a neurological disease or disorder, a neurodegenerative disease or disorder, a central nervous system disease or disorder, a psychiatric disease or disorder, a disease or disorder arising from central nervous system trauma, a disease or disorder arising from physical trauma, a disease or disorder arising from mental and/or emotional trauma.

### Claim 33 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements are capable in whole and/or in part of diagnosing, remedying, inhibiting, mitigating, and/or preventing one or more types of cancers selected from a primary cancer, a metastatic cancer, a cancer comprising a disease or disorder of epidermal growth factor or another growth factor, a cancer comprising a disease or disorder of the p53 gene or another genetic element, a cancer comprising a disease or disorder of cellular elements and processes comprising endocytosis, exocytosis, mitosis, trafficking, signaling, receptor upregulation and/or receptor downregulation.

### Claim 34

(canceled)

### Claim 35 (depends on 1)

A selectively configurable, isolated protein element according to claim 1 and one or more acceptable routes of administration for one or more acceptable compositions of elements to treat one or more biological species selected from humans, animals, plants, insects, and fungi, said routes comprising aerosol, catheter infusion, enteral, epicutaneous, epidural, inhalation, intraarterial, intracardiac, intracerebral, intracerebroventricular, intramuscular, intraosseus, intraperitoneal, intrathecal, intravenous, intravitreal, nasal, parenteral, subcutaneous, topical, transdermal, transmucosal applications.

### Claim 36 (depends on 1)

A method to treat one or more biological species selected from humans, animals, plants, insects, and fungi comprising administering to one or more selected species one or more acceptable compositions of claim 1, said compositions selected in one or more combinations from anti-parasitic agent, antibacterial agent, antibiotic, antibody, antineoplastic agent, antiviral agent, assay, biological, biological agent, cellular, cell membrane fusion agent, cell organelle agent, cell penetrating agent, cell protection agent, cell receptor downregulation agent, cell receptor upregulation agent, cell regeneration agent, cell restorative agent, cell signaling regulatory agent, cell trafficking regulatory agent, cellular agent, central nervous system agent, chemical, chemical agent, chemotherapy, contrast agent, cytosol agent, cytostatic agent, diagnostic, drug design, drug discovery, drug fabrication, drug modifier, drug regulatory agent, drug research and development, endocytosis regulatory agent, epidermal growth factor agent, exocytosis regulatory agent, genetic regulatory agent, genetic, growth factor agent, hormonal regulatory agent, immunological disease agent, implant, infectious disease agent, large molecule, ligand, mitosis regulatory agent, nano-device, nano-prosthetic, nano-scale biosensor, nanoparticle, neurological agent, non-immunogenic, non-immunogenic agent, non-toxic, non-toxic agent, nuclear medicine, nuclear medicine agent, organ, organ functioning agent, circulatory, circulatory agent, osmotic, osmotic agent, p53 gene regulatory agent, pharmaceutical, psychotropic agent, radioactive, radioactive agent, small molecule, targeted drug delivery, targeted therapy, therapeutic, tissue, tissue agent, trauma agent, vaccine elements.

### Claim 37 (depends on 36)

The method of claim 36, wherein one or more said compositions comprise one or more types of selected species-acceptable pharmaceutical carriers selected from aerosol, agricultural, airborne, adhesive, apparel, bandage, biological, biomedical, biomedical device, capsule, chemical, chemical compound, chewable, clothing, crystal, edible, food, gas, hydrogel, injection, liquid borne element, liquid, nano-device, nano-particle, powder, subcutaneous, syrup, tablet, topical elements.

### Claim 38 (depends on 36)

The method of claim 36, wherein the step of administering further comprises delivering one or more said compositions selected from aerosol, catheter infusion, enteral, epicutaneous, epidural, inhalation, intraarterial, intracardiac, intracerebral, intracerebroventricular, intramuscular, intraosseus, intraperitoneal, intrathecal, intravenous, intravitreal, nasal, parenteral, subcutaneous, topical, transdermal, transmucosal applications.

### Claim 39 (depends on 1)

A method selected from acceptable processes to manufacture one or more medicament products acceptable for use in one or more biological species selected from humans, animals, plants, insects, and fungi, said products comprised of one or more configurations of claim 1, and said products comprised in whole and/or in part of one or more compositions of elements selected in one or more combinations from anti-parasitic agent, antibacterial agent, antibiotic, antibody, antineoplastic agent, antiviral agent, assay, biological, biological agent, cellular, cell membrane fusion agent, cell organelle agent, cell penetrating agent, cell protection agent, cell receptor downregulation agent, cell receptor upregulation agent, cell regeneration agent, cell restorative agent, cell signaling regulatory agent, cell trafficking regulatory agent, cellular agent, central nervous system agent, chemical, chemical agent, chemotherapy, contrast agent, cytosol agent, cytostatic agent, diagnostic, drug design, drug discovery, drug fabrication, drug modifier, drug regulatory agent, drug research and development, endocytosis regulatory agent, epidermal growth factor agent, exocytosis regulatory agent, genetic regulatory agent, genetic, growth factor agent, hormonal regulatory agent, immunological disease agent, implant, infectious disease agent, large molecule, ligand, mitosis regulatory agent, nano-device, nano-prosthetic, nano-scale biosensor, nanoparticle, neurological agent, non-immunogenic, non-immunogenic agent, non-toxic, non-toxic agent, nuclear medicine, nuclear medicine agent, organ, organ functioning agent, circulatory, circulatory agent, osmotic, osmotic agent, p53 gene regulatory agent, pharmaceutical, psychotropic agent, radioactive, radioactive agent, small molecule, targeted drug delivery, targeted therapy, therapeutic, tissue, tissue agent, trauma agent, vaccine elements.

### Claim 40 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more supplementary configurations of elements comprise in whole and/or in part one or more acceptable elements in one more combinations selected from acoustic, adaptor protein, algorithmic, amino acid, analog, analysis, anti-parasitic agent, antibacterial agent, antibiotic agent, antibody, antineoplastic agent, antiviral agent, assay, attached, bilayer lipid membrane, biochip, biodegradable, bioengineered, biofilm, biologic, biological agent, biological, biomaterial, biomedical device, biomedical, biomolecular, blood brain barrier passing, capsid, carbon nanotube, carbonate, cargo, Casimir effect, cavity forming, cellular, cell accessing, cell communication, cell membrane crossing, cell membrane fusion element, cell modifying, cell organelle accessing, cell organelle agent, cell organelle, cell penetrating agent, cell protection agent, cell receptor downregulation agent, cell receptor upregulation, cell regeneration agent, cell restorative agent, cell signaling regulatory agent, cell signaling, cell trafficking regulatory agent, cell trafficking, cell-protecting, cell-regenerating, cell, central nervous system agent, cetyl alcohol-based, chemical, chemotherapy agent, Clifford algebra, circulatory repair, CNS synaptic space traversing, coating, communications, conductor, contrast agent, control, controlled-release, conversion, converter, cosmetic, cosurfactant, Coulomb blockade, covalent, cross-linker, crystal, cybernetic, cytosol agent, cytosol entering, cytosol, cytostatic agent, dendrimer, diagnostic agent, diagnostic, dielectric, digital, dissociation, DNA, drug administration, drug carrier, drug delivery, drug design agent, drug discovery agent, drug fabrication agent, drug modifier agent, drug regulatory agent, drug research and development agent, drug, electrical, electromagnetic, electron paramagnetic resonance, electronic, element sequestration, endocytosis regulatory agent, endocytosis, endogenous, endohedral, ENDOR, energy conversion, energy emitting, energy storage, enhancement, entirety coating, epidermal growth factor, ESR, exocytosis regulatory agent, exocytosis, exogenous, ferritin, fixed, fluid, fluorescent, free floating, fullerene, functionalization, functionalized, fusion, gas, gate, genetic agent, genetic regulatory agent, genetic, genetically engineered, genetically modified, genotype, goal-directed, graph, growth factor agent, healthcare, heat shock protein, heterogeneous, homogeneous, hormonal regulatory agent, hybrid, hydrogel, imaging, immunological disease agent, implant agent, in situ, in vitro, in vivo, infectious disease agent, information processing, inorganic, input, insulator, interconnection, iron oxide, isolated, large molecule, laser, lie algebra, ligand, light sensitive, linker, lipid, liposome, lithographic, logical, mechanical, medical, medicine, membrane, MEMS, metabolic, metabolite, metal, micelle, mitosis regulatory agent, mitosis, mixed use, modification, molecular addend, molecular bridge, molecular label, molecular tether, monitoring, MRI, nano-device, nano-prosthetic agent to supplement or enhance cell, nano-scale biosensor element, nanogel, nanoparticle element, nanotube, natural, neurological agent, nitroxide, NMR, non-covalent, non-hydrophobic, non-immunogenic, non-targeted, non-toxic agent, nontoxic, nuclear medicine agent, nutritional, optical, organ repair, organic, osmotic agent, output, oxide, p53 gene, partial coating, PEGylation, peptide, personalized, PET, pH, pharmaceutical, phenotype, photoelectric, photonic dot, photonic, photosensitized, polybutylcyanoacrylate, polymer, polypeptide, polysorbate, probe, prosthetic, protein, psychotropic agent, quantum dot, quantum mechanical, radiation, radioactive agent, radioactive, radiodiagnostic, readout, receptor downregulation, receptor upregulation, recombinant, recording, regulation, remediation, removal, reporter, RNA, scaffolding, self-adapting, self-assembling, self-regenerating, self-regulating, self-repairing, self-replicating, semiconductor, sensor, sequestration, shielded, silicate, silicon, small molecule, solid, solvent, sonic, spin label, stabilizing, substance, supplement, surfactant, switch, synthetic, targeted drug delivery agent, targeted therapy agent, targeted, temporal, test, therapeutic, therapy, thermal, tissue, toxin, trauma agent, tubule, ultrasound, uncoating, vaccine, vapor, vault ribonucleoprotein, virus, 2-D geometry, 3-D geometry elements.

### Claim 41 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein one or more compositions of elements comprise in whole and/or in part self-assembled elements.

### Claim 42 (depends on 1)

A selectively configurable, isolated protein element according to claim 1, wherein multiple isolated protein elements comprise multiple configurations of elements comprising multiple compositions acceptable for use as in vivo and/or in vitro medicaments in one or more biological species.
